Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085551 · ClinicalTrials.gov registry record · NA
Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery
A NA study of Peripheral Arterial Occlusion or Emboli, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 5
- Study locations
NCT02085551 is a NA study of Peripheral Arterial Occlusion or Emboli that has completed, run by Penumbra. The registered enrollment target is 85 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT02085551, a NA study of Peripheral Arterial Occlusion or Emboli, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores and procedural serious adverse events are assessed and recorded.
Conditions Studied
Interventions
- DEVICE Mechanical Thrombectomy by the Indigo System
Study Locations (5)
California
- Tri-City Medical Center - San Diego
Florida
- Baptist Health South Florida - Miami
Illinois
- Rush University Medical Center - Chicago
North Carolina
- Carolinas Medical Center - Charlotte
North Dakota
- Sanford Medical Center - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02085551
The ClinicalTrials.gov registry entry for NCT02085551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Occlusion or Emboli appearing as the primary indexed condition, and to 1 intervention - of which Mechanical Thrombectomy by the Indigo System is the first listed.
NCT02085551 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT02085551 about?
NCT02085551 is a clinical study titled "Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery". The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, ...
What is the current status of trial NCT02085551?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2014-03. Estimated completion is 2015-09.
What conditions does trial NCT02085551 study?
This clinical trial studies the following conditions: Peripheral Arterial Occlusion or Emboli.
What interventions are being tested in trial NCT02085551?
The interventions under investigation include: Mechanical Thrombectomy by the Indigo System (DEVICE).
Who is sponsoring clinical trial NCT02085551?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02085551 being conducted?
This trial has 5 study locations across California, Florida, Illinois, North Carolina, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.